Channels Population pharmacokinetic models describing drug-drug interactions and variability in HIV infected South Africans on protease inhibitor-based antiretroviral regimens with and without tuberculosis
Drug-drug interactions between antiretrovirals and bedaquiline
Nonlinear mixed-effects modelling of drug-drug interactions between antiretroviral therapy and tuberculosis treatment
Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
Drug-drug interactions between antiretrovirals and fluconazole in HIV-infected patients
Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance
Pharmacokinetics and safety of first -- and second--line anti-- tuberculosis drugs in children
The pharmacokinetics and toxicity of antituberculosis agents and other co-administered drugs in children with tuberculosis, with and without HIV infection, and their relationship to nutritional status
Optimization of 1st-line antituberculosis dosing regimens using a population pharmacokinetic approach: food effects, drug combinations and pharmacological effects
Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
In silico Drug Repurposing of Anticancer Drug 5-FU and Analogues Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics Simulation, Pharmacokinetics and Chemical Reactivity Studies
Tenofovir based regimens associated with less drug resistance in hiv-1 infected nigerians failing first-line antiretroviral therapy.
In vitro assessment of some traditional medications used in South Africa for pharmacokinetics drug interaction potential
And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen
Strategies for optimising TB-HIV co-treatment in children and adolescents with drug-susceptible tuberculosis on rifampicin-based standard regimens
Proteases and protease inhibitors involved in plant stress response and acclimation
Pharmacokinetic Herb-Drug Interactions involving african traditional medicines - fingerprint analysis and in vitro metabolism studies
Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy
Detection of protease and protease inhibitors during development of soybean crown nodules
Preclinical pharmacokinetic evaluation of novel antimalarial and antituberculosis drug leads
Supramolecular modification of selected antiretroviral drugs
Variability in the pharmacokinetics of rifapentine in South African tuberculosis patients : a classical and population approach
Investigation of the efficacy of identified acetolactate synthase inhibitors, peptidyl cysteine protease inhibitors, thiolactomycins, and thiosemicarbazone compounds against Mycobacterium tuberculosis
Pharmacokinetic herb-drug interaction study of selected traditional medicines used as complementary and alternative medicine (CAM) for HIV/AIDS
The effects of HIV protease inhibitors on the rat heart
